Abstract
Enoxaparin, a low-molecular-weight heparin, is one of the most useful anticoagulant. Treatment that have large using area including myocardial infarction. In this case a 65 years old male patient presenting with myocardial infarction and hemarthrosis caused by enoxaparin to be told. Patient admitted to the emergency service by angina and referred to us. After the first evaluation he hospitalized because of subacute anterior myocardial infarction. Including liver and renal function tests, platelets were normal. Medical treatment put in order. Enoxaparin was choosing as anticoagulant. During the treatments there was no problem but after last enoxaparin dose oedema was occurred at is left knee. We consulted him to orthopaedics. They did arthrocentesis to determine if it was hematoma or septic arthritis. Complete blood cells count evaluated. WBC 6.1, plt 45, Hb 10.6 detected. So it was hemarthrosis accepted. They recommend elastic bandage, elevation and cold execution. Enoxaparin treatment maintained. The day after oedema regressed. Coronary angiography done and stent implanted. Enoxaparin stopped Oedema followed by daily period, it gone back day by day. After the end of myocardial infarction treatment, he discharged.
Highlights
Enoxaparin, a low-molecular-weight heparin, is one of the most useful anticoagulant treatments that have large using area including myocardial infarction
A 65-year-old man admitted to the emergency service by angina and referred to us
During the treatment there was no problem but after last enoxaparin dose oedema was occurred at his left knee
Summary
Enoxaparin, a low-molecular-weight heparin, is one of the most useful anticoagulant treatments that have large using area including myocardial infarction. Factors that increase the risk of bleeding are high doses, advanced age, renal impairment and use of drugs which affect haemostasis at the same time [1,2]. A 65-year-old man admitted to the emergency service by angina and referred to us.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have